How Sericin and Hydroxychloroquine Team Up to Fight Lung Cancer in Mice

There's an interesting team-up happening in the world of science. Researchers found that sericin and hydroxychloroquine (HQ) can work together to reduce lung damage and even prevent early stages of lung cancer in mice. This duo targets a specific pathway in the body called PI3K/Akt/Nrf2/NF-κB. By taming this pathway, they can control oxidative stress and inflammation triggered by a nasty chemical called diethylnitrosamine (DEN). So, what did they do? They split male Swiss albino mice into different groups and gave them various treatments. When mice were exposed to DEN, their lungs became both stressed and inflamed. But, when treated with sericin and HQ together, the lungs calmed down. These superheroes boosted antioxidant levels and lowered inflammatory signals, like TNF-α and IL-6. Plus, they even increased the good guy, IL-10. The treatment also kept lung cells from growing out of control, reducing signs of cancer. Lung tissue looked healthier in mice treated with sericin and HQ, compared to those just given DEN. This dynamic duo could be a promising way to slow down lung cancer progression.